Dose-Deescalated 3-Fraction Stereotactic Body Radiotherapy For Centrally Located Lung Cancer
NCT04210492
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
36
Enrollment
OTHER
Sponsor class
Conditions
Non-small Cell Lung Cancer
Interventions
RADIATION:
45 Gray (Gy) regimen
Sponsor
Yale University